Medicare Enrolled
Dr. Llewelyn Rao, MD
Ophthalmology · Beachwood, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rao?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rao
Dr. Llewelyn Rao is an ophthalmology specialist in Beachwood, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rao performed 46,003 Medicare services across 5,608 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rao received a total of $58,350 from 31 pharmaceutical and/or device companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in OH
$58,350 industry payments
Medicare Practice Summary
Medicare Utilization ↗46,003
Medicare services
Top 0% in OH for ophthalmology
5,608
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,421 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
30,780 | $29 | $76 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
3,745 | $27 | $78 |
| Aflibercept eye injection (Eylea) | 2,286 | $690 | $1,800 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
2,067 | $86 | $253 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
1,470 | $120 | $308 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
1,301 | $60 | $172 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
879 | $80 | $242 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
709 | $84 | $248 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
677 | $11 | $32 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
378 | $52 | $319 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
329 | $158 | $400 |
| Injection, brolucizumab-dbll, 1 mg | 312 | $248 | $628 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
209 | $109 | $324 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
164 | $24 | $75 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
135 | $1,756 | $4,582 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $62 | $178 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
84 | $1 | $8 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
75 | $16 | $48 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
63 | $96 | $258 |
| Retinal laser destruction of growth A laser procedure used to destroy abnormal growths in the retina. |
32 | $385 | $986 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $43 | $110 |
| Retinal membrane and internal limiting membrane removal A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina. |
23 | $855 | $2,184 |
| Retinal laser treatment for leaking blood vessels This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels. |
21 | $242 | $2,000 |
| Injection into eye membrane A procedure involving the injection of a drug or substance into the membrane that covers the eyeball. |
20 | $37 | $100 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
19 | $669 | $1,708 |
| Retinal photocoagulation to prevent detachment This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye. |
19 | $161 | $492 |
| Retinal detachment repair with fluid drainage A surgical procedure to reattach a detached retina by draining excess fluid from the space between the lens and the retina. |
16 | $890 | $2,272 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
16 | $36 | $98 |
| Insertion of prosthetic lens | 15 | $287 | $1,466 |
| Removal of implant material from inside of eye This procedure involves the surgical removal of implant material located within the interior of the eye. |
15 | $630 | $1,722 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
11 | $102 | $286 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$58,350
Total received (2018-2024)
Avg $8,336/year across 7 years
Top 5% in OH for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
282
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,519 (40.3%)
Other
Charitable contributions, space rental, and other categories
$17,010 (29.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,989 (13.7%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$7,967 (13.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,865 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,274
2023
$4,318
2022
$18,487
2021
$24,950
2020
$1,514
2019
$2,572
2018
$1,234
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$2,435
Alimera Sciences, Inc.
$1,506
Regeneron Healthcare Solutions, Inc.
$360
Dutch Ophthalmic, USA
$279
Apellis Pharmaceuticals, Inc.
$209
Astellas Pharma US Inc
$158
ABBVIE INC.
$145
Genentech, Inc.
$93
Harrow Eye, LLC
$68
Coherus Biosciences Inc.
$21
Top 3 companies account for 81.6% of 2024 payments
All-time payments by company (2018-2024) ›
US Retina LLC
$24,977
Carl Zeiss Meditec, Inc.
$18,028
Genentech USA, Inc.
$5,308
Alimera Sciences, Inc.
$3,318
Regeneron Healthcare Solutions, Inc.
$1,670
Dutch Ophthalmic, USA
$826
NotalVision
$620
Allergan Inc.
$523
Apellis Pharmaceuticals, Inc.
$449
Allergan, Inc.
$394
ABBVIE INC.
$353
Novartis Pharmaceuticals Corporation
$298
Astellas Pharma US Inc
$272
Coherus Biosciences Inc.
$236
Bausch & Lomb, a division of Bausch Health US, LLC
$224
Notal Vision, Inc.
$159
Bausch & Lomb Americas Inc.
$136
EyePoint Pharmaceuticals US, Inc.
$101
Genentech, Inc.
$93
Harrow Eye, LLC
$68
Biogen, Inc.
$67
Rayner Intraocular Lenses Limited
$54
Kala Pharmaceuticals, Inc.
$27
Ivantis, Inc
$25
Mallinckrodt Hospital Products Inc.
$24
Ocular Therapeutix, Inc.
$18
Johnson & Johnson Surgical Vision, Inc.
$18
Alcon Vision LLC
$17
Exeltis, USA Inc.
$16
Omeros Corporation
$16
Shire North American Group Inc
$13
Top 3 companies account for 82.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BIOTRUE · BIOTRUE ONE DAY · CIRRUS HD-OCT · CLARUS 700 · Cimerli · DEXTENZA · DEXYCU · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ForeseeHome · HYDRUS Microstent · Hydrus Microstent · ILUVIEN · INVELTYS · Iluvien · Izervay · Lucentis · OZURDEX · Omidria · PURIFIED CORTROPHIN GEL · SUSVIMO · Susvimo · Syfovre · TRIESENCE · Tecnis Simplicity · VABYSMO · Vabysmo · XIIDRA · XIPERE · YUTIQ · combined machine
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (40%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for ophthalmology in OH.
Geographic Context
Ophthalmologists within 10 mi
153
Per 100K population
12.2
County median income
$62,823
Nearest hospital
SOUTH POINTE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rao is a mixed practice specialist, with above-average Medicare volume (top 0% in OH), with consulting-driven industry engagement in the top 5% of OH peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rao experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Rao performed 30,780 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rao receive payments from pharmaceutical companies?
Yes. Dr. Rao received a total of $58,350 from 31 companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rao's costs compare to other ophthalmologists in Beachwood?
Dr. Rao's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Beachwood
Browse ophthalmologists in Beachwood ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in OH
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in OH
Which OH ophthalmologists receive the most from drug and device companies.
By company
US Retina LLC Payments to Doctors
See all physicians who received payments from US Retina LLC.
By company
Carl Zeiss Meditec, Inc. Payments to Doctors
See all physicians who received payments from Carl Zeiss Meditec, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology